Chris Tame
Founder & Chief Executive Officer Ternary Therapeutics
A drug discovery leader with expertise in the development and application of innovative technologies to disrupt drug discovery, including AI and Targeted Protein Degradation.
Experience in building and applying machine learning products for drug design and target identification.
Seminars
Monday 27th October 2025
Workshop A – Discovering Ligase-Target Pairings to Kick-Start Molecular Glue Discovery Programs & Enable Rational Drug Design
8:30 am
When starting molecular glue development from scratch, finding the right interaction to stabilize is the most crucial
step. In this workshop, you will learn to decode targetligase pairs and accurately visualize ternary complexes to accelerate molecular glue discovery. We will cover:
- How to identify the right target-ligase pairings with high-throughput assays
- Choosing the best libraries, assays, and biophysical methods to discover and validate hits for molecular glue development
- Using in silico modeling to optimize ternary complex visualization
